SCHEMBL424812

SCHEMBL424812

Cc1cc(C)c([S+](c2ccccc2)c2ccccc2)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.40
CYP2A6 P11509 1/20 0.40
TSHR P16473 2/20 0.38
ACHE P22303 2/20 0.38
LMNA P02545 2/20 0.38
ALOX12 P18054 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
PSMB5 P28074 2/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
RAB9A P51151 1/20 0.33
MAPT P10636 1/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3144004 0.98 CYP1A2 (0.39) CYP1A2CYP2A6TSHRACHELMNA
Hydrochloric Acid SCHEMBL6764989 0.98 CYP1A2 (0.39) CYP1A2CYP2A6TSHRACHELMNA
SCHEMBL3183538 0.95 CYP1A2 (0.40) CYP1A2CYP2A6TSHRACHELMNA
SCHEMBL3136259 0.92 CYP1A2 (0.35) CYP1A2CYP2A6TSHRACHELMNA
Perchlorate SCHEMBL3132324 0.92 CA12 (0.36) CYP1A2CYP2A6TSHRACHELMNA
SCHEMBL3126244 0.89 CYP1A2 (0.33) CYP1A2CYP2A6TSHRACHELMNA
SCHEMBL3139354 0.89 CYP1A2 (0.33) CYP1A2CYP2A6TSHRACHELMNA
SCHEMBL11903936 0.87 ACHE (0.44) CYP1A2CYP2A6TSHRACHEFFAR4
SCHEMBL5066033 0.87 FFAR4 (0.45) TSHRLMNAALOX12FFAR4MEN1
SCHEMBL5066003 0.87 FFAR4 (0.41) LMNAALOX12FFAR4MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2326744-B1 METAL COMPOSITIONS AND METHODS OF MAKING SAME PRYOG LLC (US) 2022-06-01 EP claimed
EP-2856519-A1 PHOTOACTIVATED ETCHING PASTE AND ITS USE Merck Patent GmbH (DE) 2015-04-08 EP claimed
WO-2013182265-A1 PHOTOACTIVATED ETCHING PASTE AND ITS USE MERCK PATENT GMBH (DE) 2013-12-12 WO claimed
EP-2078028-B1 PHOTOACTIVE COMPOUNDS AZ ELECTRONIC MATERIALS USA (US) 2011-09-07 EP claimed
EP-2102156-A2 PHOTOACTIVE COMPOUNDS AZ Electronic Materials USA Corp. (US) 2009-09-23 EP claimed
WO-2008068610-A2 PHOTOACTIVE COMPOUNDS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2008-06-12 WO claimed
US-20050158657-A1 Radiation-sensitive resin composition SUZUKI AKI (JP) 2005-07-21 US claimed
US-6899989-B2 Radiation-sensitive resin composition JSR CORPORATION (JP) 2005-05-31 US claimed
US-20020090569-A1 Radiation-sensitive resin composition JSR CORPORATION (JP) 2002-07-11 US claimed
WO-2026100410-A1 IODINE-CONTAINING POLYMERIZABLE COMPOUND AND IODINE-CONTAINING POLYMER 三菱瓦斯化学株式会社 2026-05-15 WO disclosed
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-20260035592-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT TOKUYAMA DENTAL CORPORATION (JP) 2026-02-05 US disclosed
US-20250362597-A1 RESIST COMPOSITION AND RESIST FILM FORMING METHOD USING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-11-27 US disclosed
EP-4222219-B1 CURABLE SILICONE COMPOSITION AND CURED PRODUCT THEREOF DOW SILICONES CORP (US) 2025-11-05 EP disclosed
US-20020090569-A1 Radiation-sensitive resin composition JSR CORPORATION (JP) 2002-07-11 US disclosed
EP-1128212-A2 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-08-29 EP disclosed
US-20010016298-A1 Chemically amplified positive resist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-08-23 US disclosed
US-6183934-B1 FOE USE IN FORMATION OF PATTERN OF INSULATION FILM, PASSIVATION FILM, .ALPHA.-RAY SHIELDING FILM, OPTICAL WAVEGUIDE KABUSHIKI KAISHA TOSHIBA (JP) 2001-02-06 US disclosed
CN-1263612-A Chemically amplified resist composition CLARIANT INT LTD (CH) 2000-08-16 CN disclosed
EP-1024406-A1 Resist composition WAKO PURE CHEMICAL INDUSTRIES LTD (JP) 2000-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 CYP1A2 3178/4885CYP2A6 3766/4885TSHR 967/4885
US-20260035592-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT TERB1, CAD, C9 CYP1A2 2760/4885CYP2A6 3042/4885TSHR 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.